LIQUID ENTERAL NUTRIENT COMPOSITION SUITABLE FOR ENTERAL FEEDING, MINIMISING UPPER AND LOWER GASTROINTESTINAL COMPLICATIONS Russian patent published in 2014 - IPC A23L1/29 A23L1/30 A23L1/305 

FIELD: medicine.

SUBSTANCE: liquid enteral nutrient composition contains a protein fraction containing 25 wt % to 80 wt % of vegetable protein with at least a source of intact pea protein, wherein the protein fraction additionally contains milk protein specified in a group consisting of casein, including micellar casein and caseinate, and serum protein, and an oil fraction. The oil fraction contains: 8 to 15 wt % of linoleic acid (LA); 3.0 to 6.0 wt % of a combination consisting of ω-3 polyunsaturated fatty acids alpha-linolenic acid (ALA), docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), wherein an amount of ALA is >2.5 wt %, while a combination amount of DHA and EPA is ≤2.5 wt %; 10 to 20 wt % of at least one medium-chain fatty acids (MCFA) and 35 to 79 wt % of at least one monounsaturated fatty acid (MUFA), wherein all the relative amounts are calculated of the total amount of fatty acids in the oil fraction. As a version, the liquid enteral nutrient composition contains a protein fraction containing 20 to 40 wt % of casein, 20 to 40 wt % of serum protein, 13 to 25 wt % of soya protein and 13 to 25 wt % of pea protein in relation to total protein in the protein fraction, wherein the total amount of proteins is equal to 100 wt %. Also, the composition contains an oil fraction containing 13.5 to 13.9 wt % of LA; 4.3 to 4.7 wt % of a combination consisting of ω-3 polyunsaturated fatty acids ALA, DHA and EPA, wherein an amount of ALA is >2.7 wt %, or wherein an amount of ALA makes 2.5 to 4.0 wt %, and a combination amount of DHA and EPA is ≤1.0 wt %; 15.7 to 16.2 wt % of at least one MCFA and 50 to 60 wt % of at least one MCFA, wherein all the relative amounts are calculated of the total amount of fatty acids in the oil fraction. The composition also contains a carbohydrate fraction and optionally a food fibre fraction. The prepared compositions are used for enteral feeding, particularly for long-term enteral feeding. Also, the compositions are applicable for preventing and/or treating upper and/or lower gastrointestinal complications in the patients having enteral feeding.

EFFECT: invention enables minimising the clinical complications related to the enteral feeding in the patients when using a probe, particularly delayed gastrointestinal evacuation.

26 cl, 8 tbl, 2 ex